AVAX Technologies, Inc. · Philadelphia, PA United States (OTC: AVXT)
| 2000 Hamilton St., Ste. 204 | Phone: 215-241-9760 |
| Philadelphia, PA | Fax: 215-241-9684 |
| 19130 | |
| United States | 
Map This Company |
AVAX Technologies, Inc. Rankings
More Companies in These Related Industries: Biologics MfgCompany Description
AVAX Technologies wants to turn cancer cells into cancer fighters. The company is developing vaccines created by extracting a patient's own cancer cells and chemically treating them to induce an immune system response. The technology used to create the vaccines (called AC Vaccine) is licensed from
AVAX Technologies, Inc. Reports
No subscription, no problem.
Download presentation-ready reports. From company profiles to the competitive landscape, Hoover's offers immediate access to individual reports.
Financials
| Company Type | Public - OTC: AVXT Single Location |
|---|---|
| Fiscal Year-End | December |
| Employees | 29 |
Executives
6 executives listed for AVAX Technologies, Inc.'s Philadelphia, PA location.
| Chairman and CEO | John Prendergast | |
|---|---|---|
| CFO and Director | Richard Rainey | |
| General Manager, Génopoïétic | Andrés Crespo |